Grand Rounds: Big Data Meets Health Care: The Case for Comparability and Consistency

Christopher Chute, M.D., presents Big Data Meets Health Care: The Case for Comparability and Consistency.

Grand Rounds: Less Invasive Axillary Surgery After Neoadjuvant Chemotherapy in Women who Present With Node-Positive Breast Cancer — Results From a Prospective Clinical Trial: ACOSOG Z1071

Judy C. Boughey, M.D., presents Less Invasive Axillary Surgery after Neoadjuvant Chemotherapy in Women who Present With Node-Positive Breast Cancer — Results From a Prospective Clinical Trial: ACOSOG Z1071.

Grand Rounds (CME): Pulmonary Parenchymal Disease and Lung Cancer: Automatic Disease Characterization and Stratification from HRCT Data

Pulmonary Parenchymal Disease and Lung Cancer: Automatic Disease Characterization and Stratification from HRCT Data by Brian Bartholmai, MD.

Grand Rounds: Preparing a Competitive Application to the Patient Centered Outcomes Research Institute

Erik Hess, MD and Glenn Smith, PhD, LP presents Preparing a Competitive Application to the Patient Centered Outcomes Research Institute.

Warfarin Genetic Test Study Results

Thomas Moyer, Ph.D., from the Department of Laboratory Medicine and Pathology at Mayo Clinic, describes how hospitalization rates for heart patients taking warfarin, the worlds most-prescribed blood thinner, dropped by approximately 30 percent.

Colon cancer study

An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of people with metastatic colorectal cancer, an international phase III clinical trial found.